ClinicalTrialsFinder

Leukemia, Acute Myelogenous (AML) Clinical Trials in Guangzhou, Guangdong

1 recruitingGuangzhou, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

Myelodysplastic SyndromesLeukemia, Acute Lymphocytic (ALL)Leukemia, Acute Myelogenous (AML)
Zhujiang Hospital30 enrolled1 locationNCT03291444